Stocks Update: Eton Pharma, Match Group, and Trump Media & Tech
Eton Pharmaceuticals' stock soars 11% as the FDA accepts its new drug application for hydrocortisone oral solution. Activist investor...
Revolutionize Your Finance News Experience with MorningExpert!
🌟 Custom-Tailored News Just for You: Say goodbye to information overload. Our cutting-edge filtering technology curates your feed to perfection, delivering only the finance news that matches your interests and professional ambitions.
🔔 Flexible Updates, Your Way: How do you like your updates? Choose from instant app notifications, email digests, or captivating video summaries to stay informed on your own terms.
🎥 Engaging Video Summaries: Pressed for time? Let our expert anchors brief you with video summaries, giving you the essence of each news piece in minutes.
🚨 Personalized Alerts: Never miss out on what matters most. Set custom alarms for topics you’re passionate about, and be the first in the know.
📹 Create Your Own Video Content: Dive deeper into the topics that intrigue you with personalized videos. Generated on demand, these videos bring your chosen keywords or interests to life.
MorningExpert is more than a news app; it’s a dedicated companion for anyone passionate about finance. Whether you’re a seasoned professional, an avid enthusiast, or simply eager to stay updated with the finance world, our app ensures you’re always ahead of the curve.
With features designed to make staying informed effortless and enjoyable—such as custom alarms and on-demand video content—navigating the finance landscape has never been simpler or more tailored to your needs.
Transform the way you consume finance news. Download MorningExpert now and step into a world of precision-informed finance knowledge. Your next-level finance journey starts here!
acquisition adjusted earnings AI analysts apple artificial intelligence Bitcoin CEO China demand dividend Donald Trump Dow Jones Industrial Average earnings economy extreme event FactSet Federal Reserve fourth quarter growth guidance hamas inflation interest rates investment investors Israel Microsoft net income net profit Nvidia profit revenue revenue growth S&P 500 sales shareholders shares stock stock market stocks tesla third quarter Trump Wall Street
Eton Pharmaceuticals' stock soars 11% as the FDA accepts its new drug application for hydrocortisone oral solution. Activist investor...
In a surprising turn of events, Lexicon Pharmaceuticals' shares surged by 5.5% to $2.29 in pre-market trading following the...
The U.S. FDA has accepted BridgeBio Pharma's New Drug Application for acoramidis, an investigational drug for Transthyretin Amyloid Cardiomyopathy....
Liquidia's shares dropped 10% in premarket trading after the U.S. Food and Drug Administration (FDA) announced that it is...
NRx Pharmaceuticals has received FDA designations for its drug NRX-101 in the treatment of urinary tract infections. The designations...
Xoma will make a $1 million milestone payment to LadRx after the FDA accepted Zevra Therapeutics' new drug application...
Shares in Alcon surged on Wednesday after the Swiss company announced positive results for its dry-eye disease treatment. The...
Eye-care company Alcon has announced positive results from two trials of its candidate treatment for dry-eye disease, AR-15512. The...
Soligenix shares surged 8% to 88 cents after the company announced that its SGX945, a potential treatment for oral...
Shares of Cingulate Inc. have skyrocketed 226.3% in premarket trading after the biopharmaceutical company announced that the delisting of...